Want to join the conversation?
$BWA 2Q15 Q&A: Patrick from Goldman Sachs asked main levers to get to that acceleration of organic growth, and Ronald replied, generally we do see some pick up in backlog in 2H versus 1H, and obviously that North American program picking up steam is helpful in that regard, and comps in 2H, which is a big variable &we are thinking about this.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?